JSM2025
Back to all people

Zhangchen Zhao

Eli Lilly and Company
2 appearances in the program

Sessions & presentations

Improving Data-Driven Clinical Decisions: Quantitative Approaches for Success
Presentation: Leveraging Mendelian Randomization for Drug Development: A Case Study using Epiregulin Antagonist
Contributed Papers · Tue, Aug 5 , 10:30 AM
First Author
Improving Data-Driven Clinical Decisions: Quantitative Approaches for Success
Presentation: Leveraging Mendelian Randomization for Drug Development: A Case Study using Epiregulin Antagonist
Contributed Papers · Tue, Aug 5 , 10:30 AM
Presenting Author
↑